BRIEF published on 05/20/2026 at 17:50, 5 months 18 days ago Mauna Kea Technologies is expanding into the Middle East Mauna Kea Technologies CellTolerance Middle East Expansion Regulatory Authorizations Irritable Bowel Syndrome
BRIEF published on 05/20/2026 at 17:50, 5 months 18 days ago Mauna Kea Technologies s'étend au Moyen-Orient Mauna Kea Technologies Autorisations Réglementaires CellTolerance Expansion Moyen-Orient Syndrome De L'intestin Irritable
PRESS RELEASE published on 05/20/2026 at 17:45, 5 months 18 days ago Informations privilégiées / Autres communiqués Mauna Kea Technologies obtient des autorisations réglementaires aux Émirats Arabes Unis et en Turquie pour CellTolerance. Expansion commerciale dans une région avec forte prévalence du syndrome de l'intestin irritable Expansion Commerciale Mauna Kea Technologies Autorisations Réglementaires CellTolerance Syndrome Intestin Irritable
BRIEF published on 05/18/2026 at 17:50, 5 months 20 days ago Mauna Kea Technologies Proposes New Board Members Annual General Meeting Shareholder Voting Strategic Transformation Board Nominations Mauna Kea Technologies
BRIEF published on 05/18/2026 at 17:50, 5 months 20 days ago Mauna Kea Technologies propose de nouveaux membres au conseil d'administration Assemblée Générale Annuelle Transformation Stratégique Vote Des Actionnaires Nominations Au Conseil D'administration Mauna Kea Technologies
PRESS RELEASE published on 05/18/2026 at 17:45, 5 months 20 days ago Inside Information / Other news releases Mauna Kea Technologies nominates 3 new directors to accelerate strategic transformation in 2025. Shareholder approval awaited for upcoming Annual General Meeting Annual General Meeting Shareholder Approval New Directors Strategic Transformation Mauna Kea Technologies
BRIEF published on 04/15/2026 at 17:50, 6 months 22 days ago Mauna Kea Technologies en forte croissance au T1 2026 Chiffre D'affaires Croissance Cellvizio Technologies Médicales Intolérances Alimentaires
BRIEF published on 04/15/2026 at 17:50, 6 months 22 days ago Mauna Kea Technologies to experience strong growth in Q1 2026 Revenue Growth Medical Technologies Cellvizio Food Intolerances
PRESS RELEASE published on 04/15/2026 at 17:45, 6 months 22 days ago Informations privilégiées / Autres communiqués Mauna Kea Technologies annonce une forte croissance de ses ventes au T1 2026, avec des ventes totales en hausse de +68% à taux de change constant (TCC) et +57% en publié Croissance Ventes Mauna Kea Technologies CellTolerance T1 2026
BRIEF published on 03/11/2026 at 17:50, 7 months 27 days ago Mauna Kea Technologies Achieves Milestone with CLIMB Study Mauna Kea Technologies Cellvizio Pancreatic Cysts CLIMB Study ASGE Plenary Session
Published on 11/06/2026 at 22:15, 21 hours 1 minute ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 1 day 6 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 1 day 6 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 1 day 6 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/07/2026 at 13:35, 5 hours 41 minutes ago Eurobattery Minerals board member and CEO remanded in custody in Sweden
Published on 11/06/2026 at 20:15, 23 hours 1 minute ago African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 20:15, 23 hours 1 minute ago L’Agence africaine des médicaments marque sa première année d’activité avec le lancement de nouvelles plateformes pour renforcer la réglementation et soutenir la fabrication
Published on 11/06/2026 at 19:15, 1 day ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 1 day ago Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 19:06, 1 day ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:04, 1 day ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 19:01, 1 day ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:00, 1 day ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
